Skip to main content
. 2005 Feb;11(2):191–200. doi: 10.3201/eid1102.040524

Table 1. Selected costs in the decision-analysis model*.

Costs† Low Base High Source
Vaccines and medications
   Influenza vaccine $10.00 $27.78 $40.00 11
   Antibiotics for FRI‡ $30.00 $64.72 $80.00 12
Medical care§
   Ambulatory clinic visit $40.00 $60.03 $80.00 13
   Hospitalization for FRI $5,000 $11,645 $15,000 14
   Hospitalization for influenza $7,500 $17,465 $25,000 14
   Hospitalization for PUI $15,000 $19,441 $25,000 14
   Hospitalization for SARS $20,000 $28,502 $40,000 14,15
Diagnostic tests
   Rapid influenza test $15.00 $26.86 $40.00 16
   Multiplex¶ RT-PCR $50.00 $154.02 $200.00 Prodesse Inc., pers. comm.
   SARS# RT-PCR $20.00 $54.80 $100.00 Prodesse Inc., pers. comm.
Miscellaneous
   Patient time (per hour) $15.00 $24.55 $30.00 17
   Contact investigation (per SARS contact) $100.00 $222.94 $300.00 5,18

*FRI, febrile respiratory illness; PUI, person under investigation (for SARS); SARS, severe acute respiratory syndrome; RT-PCR, reverse transcription–polymerase chain reaction.
†Medical and nonmedical costs were adjusted to 2004 U.S. dollars by using the Consumer Price Index."?
‡Antimicrobial drug costs are based on a 7-day course of oral levofloxacin.
§Includes laboratory tests, transportation costs, and patient time.
¶Detects influenza viruses A and B, respiratory syncytial viruses A and B, parainfluenza viruses 1–3, human metapneumovirus, Legionella pneumophila, L. micdadei, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Bordetella pertussis.
#Detects SARS-associated coronavirus and coronaviruses OC43 and 229E.